Back

Law firm investigates Aardvark after ARD-101 trial pause and 56.2% stock drop

Verifying
  • Lowey Dannenberg is investigating Aardvark for potential federal securities-law violations.
  • 56.2%: Aardvark shares fell to $5.47 after the February 27 trial pause.
  • FDA placed a full clinical hold on ARD-101’s application on May 14, 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Law firm investigates Aardvark after ARD-101 trial pause and 56.2% stock drop - CoinPost Terminal